Mental Practice Impact on Gait and Cortical Organization in Spinal Cord Injury (SCI)
NCT ID: NCT01302522
Last Updated: 2011-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
INTERVENTIONAL
2008-09-30
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhancing Recovery in Non-Traumatic Spinal Cord Injury
NCT03320759
Retraining Walking After Spinal Cord Injury
NCT00059553
Spinal Cord Injury Mental Health Functional Outcomes Improved by Mindfulness
NCT04972773
Health Outcomes After Locomotor Training in Spinal Cord Injury
NCT02201173
Enhancing Self-Efficacy for Caregivers of Family Members With Spinal Cord Injury
NCT02392052
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
TREATMENT
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mental practice
All patients in the study will be administered a regimen of locomotor therapy (rehabilitative therapy working on walking). Half of the patients will also be administered a regimen in which they mentally rehearse the exercises that they have just physically performed.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* incomplete SCI (ASIA Grade C or D), experienced \> 1 year prior to enrollment;
* motor grade of \> 1 \< 3 in the quads, hamstrings, and hip flexors, and ability to ambulate with at least a maximal assist;
* range of motion in the lower limbs within functional limits;
* motor function in at least half of ASIA key lower extremity muscles with strength \< or \> 3/5;
* able to ambulate at least 10 meters with 1 person assistance and/or assistive device;
* medically stable (ie, no bladder infection; decubiti); (8) stable dosage of antispasticity medications for duration of study
Exclusion Criteria
* excessive pain in the lower limbs as measured by a score of \> 5 on a Visual Analog Scale or \> 8/10 with a clarified scaled picture graph;
* moderate to severe osteoporosis, as indicated by the patient's physician;
* heterotropic ossification, as indicated by the patient's physician;
* psychological conditions that would contraindicate participation in the program and no abnormalities of attention, with minimum cognitive capacity present sufficient to participate in MP;
* fracture or fracture history in the lower limbs (individuals with a remote history of fractures may be included at discretion of the study physical therapists at each site);
* enrolled in any form of rehabilitation;
* pregnant;
* DSM-IV Major Depressive Episode symptom criteria of \> 5/9 as exclusion threshold instead of CESD;
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Cincinnati
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Cincinnati
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.